60 Minutes Season 53 Episode 22 1/31/2021: Left Behind, The Biodata Race, DNA For Sale

In episode 22 of season 53 of 60 Minutes titled "Left Behind, The Biodata Race, DNA For Sale," viewers are taken on a powerful journey of three distinct yet equally powerful stories.

The first story examines the lives of those who have been economically left behind in the wake of the COVID-19 pandemic. Through an insightful interview with U.S. Treasury Secretary Janet Yellen, 60 Minutes investigates how the pandemic has exposed and intensified the existing economic disparities that were present before the outbreak. As Yellen puts it, "We're facing a K-shaped recovery, and that means that those at the top are doing very well, but those at the bottom...are really suffering."

The second story delves into the rapidly evolving world of biodata and the ongoing competition to tap into the massive potential that analyzing this data holds. 60 Minutes correspondent Lesley Stahl sits down with the CEO of the leading biodata company, 23andMe, to discuss the potential benefits and risks of collecting and analyzing this information. Through a series of interviews with experts on both sides of the argument, viewers gain insight into the complicated ethical and privacy concerns that are inherent in this cutting-edge technology.

The final story focuses on the booming industry of direct-to-consumer genetic testing kits and the staggering amount of personal data that is being collected and sold to third-party companies. 60 Minutes correspondent Jon Wertheim investigates the potential dangers of this widespread practice, which has grown rapidly in recent years due to increased consumer demand. Through a series of eye-opening interviews with experts in the field, viewers learn about the deeply troubling implications of this trend and are left to ponder the profound consequences of commodifying the very essence of our biological selves.

As always, 60 Minutes delivers a thought-provoking and insightful exploration of some of the most pressing issues facing America today. Whether examining the ongoing struggles of those left behind by the pandemic, the cutting-edge world of biodata, or the troubling implications of the direct-to-consumer genetic testing industry, this episode delivers a powerful and compelling message about the profound ways in which technology is shaping our lives today and into the future.